We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+6.01%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$5.38B
AUM Growth
+$596M
Cap. Flow
+$425M
Cap. Flow %
7.9%
Top 10 Hldgs %
8.33%
Holding
1,582
New
122
Increased
396
Reduced
290
Closed
155

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$22.1M
2
PCG icon
PG&E
PCG
+$22.1M
3
MHK icon
Mohawk Industries
MHK
+$18M
4
HII icon
Huntington Ingalls Industries
HII
+$16.5M
5
DOX icon
Amdocs
DOX
+$14.9M

Sector Composition

Rank Sector Weight
1 Financials 21.25%
2 Industrials 14.51%
3 Technology 11.39%
4 Healthcare 11.36%
5 Consumer Discretionary 9.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUTR
801
DELISTED
Cutera, Inc.
CUTR
$906K 0.02%
70,850
VRTV
802
DELISTED
VERITIV CORPORATION
VRTV
$906K 0.02%
25,022
+5,400
+28% +$214K
CYBE
803
DELISTED
Cyberoptics Corp
CYBE
$904K 0.02%
118,200
FLIC
804
DELISTED
First of Long Island Corp
FLIC
$900K 0.02%
45,000
-225
-0.5% -$4.37K
TESS
805
DELISTED
Tessco Technologies Inc
TESS
$900K 0.02%
46,200
PINC
806
DELISTED
Premier
PINC
$899K 0.02%
25,500
NSR
807
DELISTED
Neustar Inc
NSR
$896K 0.02%
+37,400
New +$967K
OCAT
808
DELISTED
OCATA THERAPEUTICS, INC. COMMON STOCK
OCAT
$895K 0.02%
106,282
HFBC
809
DELISTED
HopFed Bancorp Inc
HFBC
$894K 0.02%
74,588
CBNK
810
DELISTED
CHICOPEE BANCORP INC COM STK
CBNK
$893K 0.02%
51,500
TNAV
811
DELISTED
Telenav Inc.
TNAV
$890K 0.02%
156,500
KVHI icon
812
KVH Industries
KVHI
$181M
$887K 0.02%
94,167
+3,900
+4% +$37.7K
IMMU
813
DELISTED
Immunomedics Inc
IMMU
$887K 0.02%
288,900
AEPI
814
DELISTED
AEP Industries Inc
AEPI
$883K 0.02%
11,450
+50
+0.4% +$3.99K
GHM icon
815
Graham Corp
GHM
$1.23B
$881K 0.02%
52,400
HCKT icon
816
Hackett Group
HCKT
$284M
$876K 0.02%
54,500
-8,000
-13% -$132K
BRKL
817
DELISTED
Brookline Bancorp
BRKL
$871K 0.02%
75,700
-100
-0.1% -$1.13K
HBIO icon
818
Harvard Bioscience
HBIO
$28.5M
$871K 0.02%
25,112
+5,000
+25% +$171K
LMAT icon
819
LeMaitre Vascular
LMAT
$2.42B
$866K 0.02%
50,200
LSAK icon
820
Lesaka Technologies
LSAK
$415M
$866K 0.02%
64,100
-550
-0.9% -$8.62K
RMAX icon
821
RE/MAX Holdings
RMAX
$207M
$866K 0.02%
23,218
+15,400
+197% +$576K
NAVB
822
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$864K 0.02%
32,494
RJET
823
DELISTED
REPUBLIC AWYS HLDGS INC
RJET
$863K 0.02%
219,654
-250,350
-53% -$1.24M
KCG
824
DELISTED
KCG Holdings, Inc.
KCG
$862K 0.02%
70,000
WIRE
825
DELISTED
Encore Wire Corp
WIRE
$860K 0.02%
23,200
+200
+0.9% +$8.11K

Similar funds

Bridgeway Capital Management's Q4 2015 Portfolio in Review

As of Q4 2015, Bridgeway Capital Management held 1,582 positions worth $5.38B, up 12% from $4.78B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

Bridgeway Capital Management deployed $425M of net new capital in Q4 2015, opening 122 new positions and adding to 396 existing holdings. Its largest new stake was Lam Research: 3,995,450 shares worth $31.7M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Mohawk Industries, an estimated $18M trimmed.

  • Bridgeway Capital Management's largest Q4 2015 buy was Lam Research: 3,995,450 shares worth $31.7M.
  • Bridgeway Capital Management added most to Berkshire Hathaway Class B in Q4 2015, an estimated $29.5M increase.
  • Bridgeway Capital Management's biggest Q4 2015 reduction was Mohawk Industries, cutting an estimated $18M.
  • Bridgeway Capital Management fully exited Celanese in Q4 2015, selling an estimated $22.1M.
  • Bridgeway Capital Management's ten largest holdings make up 8.3% of its $5.38B portfolio in Q4 2015.
  • Bridgeway Capital Management opened 122 new positions and closed 155 in Q4 2015.
  • Bridgeway Capital Management's portfolio value rose 12% quarter-over-quarter to $5.38B.

Based on Bridgeway Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.